Riluzole Improves Cognitive Function After Cranial Radiation Therapy
Author Information
Author(s): El-Khatib Sanad M., Vagadia Arya R., Le Anh C. D., Baulch Janet E., Ng Ding Quan, Du Mingyu, Johnston Kevin G., Tan Zhiqun, Xu Xiangmin, Chan Alexandre
Primary Institution: University of California, Irvine
Hypothesis
Enhancing levels of brain-derived neurotrophic factor (BDNF) in the irradiated brain will improve cognitive function.
Conclusion
Oral administration of riluzole significantly improved cognitive function and reduced neuroinflammation in mice subjected to cranial radiation therapy.
Supporting Evidence
- Riluzole treatment significantly increased hippocampal BDNF levels in irradiated mice.
- Irradiated mice receiving RZ showed improved performance in cognitive tasks compared to those receiving vehicle.
- RZ treatment reduced neuroinflammation in the irradiated brain.
- Spatial transcriptomics revealed upregulation of neuroprotective genes in RZ-treated mice.
- RZ administration preserved synaptic integrity in the hippocampus.
Takeaway
Giving a medicine called riluzole to mice that had brain radiation helped them think better and reduced brain swelling.
Methodology
Mice were given cranial radiation and then treated with riluzole for 6-7 weeks, followed by cognitive function tests and brain analysis.
Potential Biases
Potential bias in animal selection and treatment administration.
Limitations
The study was conducted on mice, and results may not directly translate to humans.
Participant Demographics
Adult male wild-type mice (C57BL/6), aged 12-13 weeks.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website